Moderna, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue: -29.1%
EBITDA: +9.7%
EBIT: +8.5%
EPS: +6.6%
Free cash flow: +60.8%
Operating cash flow: +52.7%

Forward estimates

Revenue: -8.0%
EBITDA: +83.0%
EPS: +21.3%

Three-year CAGR

Revenue: -53.1%
EBITDA: +24.8%
EBIT: +22.1%
Net income: +20.8%
EPS: +21.7%
Free cash flow: +49.1%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.